Faculty

Institution

Unit

Venue

Louis J. Ignarro

Professor Emeritus

University of California, Los Angeles

Affiliations

Samueli School of Engineering

Chemical and Biomolecular Engineering

David Geffen School of Medicine

Molecular & Medical Pharmacology

Louis J. Ignarro is currently serving as a Chemical And Biomolecular Engineering Professor Emeritus at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Louis J. Ignarro

University of California, Los Angeles

Professor Emeritus

You can click a keyword to filter the displayed items

pharmacology vascular biology physiology biochemistry health sciences membrane biology cardiology nitric oxide inflammation redox biology hematology enzymes medicinal research cardiovascular research liver physiology respiratory medicine protein science cardiovascular disease enzyme inhibition cardiovascular physiology endocrinology mammalian biology neuropharmacology circulatory physiology biochemical sciences free radical biology angiology biological chemistry cellular physiology angiogenesis hemostasis cardiovascular pharmacology molecular physiology pharmacotherapy molecular regulation endothelial dysfunction vascular disease functional modification in vivo systems human sciences human physiology cardiovascular function inhibitory activity neurochemistry human neutrophils endothelium-derived nitric oxide therapeutic efficacy brain science redox signaling treatment effects pharmacokinetics clinical pharmacology lysosomal enzyme release experimental pharmacology vascular pharmacology pharmaceutical research innate immune system heme signaling science studies cell regulation metabolic intervention guanylate cyclase arterial disease catalyst activation pharmaceutical sciences heme homeostasis nitroso compounds beneficial effects anti-inflammatory drugs nitric oxide synthase nitric oxide production pulmonary artery cyclic gmp formation endothelial cells pomegranate juice experimental autoimmune encephalomyelitis

Notable Scholarly Works

Notable Federal Grants

Collaborators

Gasotransmitter Signaling in the Brain: New Frontiers for Therapeutics. Neurotherapeutics (2025)

neuropeptide receptorsneuronsneuropsychopharmacologyneuroscienceneurophysiologypharmacology

Exacerbated Neuropathy in Polar a and M Trials Due to Redox Interaction of Pledox-Associated Mn2+ and Oxaliplatin-Associated Pt2+. Antioxidants (2023)

Jan Olof G. KarlssonPer JyngeLouis J. Ignarro

neurologypharmacologymedicineoxidative stress

Comment on “Evidence That the Properdp Method is Inadequate for Protein Persulfidation Detection Due to Lack of Specificity”. Science Advances (2021)

Éva DókaElias S. J. ArnérEdward E. SchmidtTobias P. DickAlbert van der VlietJing YangRéka SzatmáriTamás DitróiJohn L. WallaceGiuseppe CirinoKenneth OlsonHozumi MotohashiJon M. FukutoMichael D. PluthMartin FeelischTakaaki AkaikeDavid A. WinkLouis J. IgnarroPéter Nagy

biophysicsproperdp methodscientific communicationprotein scienceprotein persulfidation detectionscience advance

The Damaging Outcome of the Polar Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction Between Oxaliplatin and Pledox. Antioxidants (2021)

Jan Olof G. KarlssonPer JyngeLouis J. Ignarro

regenerative medicinepharmacologyredox biologyoncologydamaging outcome

Inhaled Nitric Oxide and Covid-19. British Journal of Pharmacology (2020)

Louis J. Ignarro

public healthinfectious respiratory diseasemedicinepharmacologycovid-19nitric oxide

May Mangafodipir or Other Sod Mimetics Contribute to Better Care in Covid-19 Patients?. Antioxidants (2020)

Jan Olof G KarlssonPer JyngeLouis J Ignarro

public healthclinical effectivenessmedicinepharmacologyoxidative stresscovid-19antioxidants

The Right Way to Breathe During the Coronavirus Pandemic. (2020)

infectious diseasesrespiratory medicinesars-cov-2lung microbiomecovid-19critical carevirus eradication

Letter in Response to: “Randomised Open Label Exploratory, Safety and Tolerability Study With Calmangafodipir in Patients Treated With the 12-H Regimen of N Acetylcysteine for Paracetamol Overdose—the Pp100-01 for Overdose of Paracetamol (Pop) Trial: Study Protocol for a Randomised Controlled Trial”. Trials (2019)

Jan Olof G. KarlssonPer JyngeIngemar LundströmLouis J. Ignarro

drug safetypharmacologyclinical pharmacologystudy protocolemergency medicineoutcomes researchpharmacotherapydrug assessmentrespiratory medicineclinical investigationopen label exploratorypatient safetyopioid overdosetoxicologyparacetamol overdoseaddiction medicineclinical epidemiologypharmacovigilancetolerability studymedicineexperimental medicineclinical research

Biological Hydropersulfides and Related Polysulfides – a New Concept and Perspective in Redox Biology. FEBS Letters (2018)

Jon M. FukutoLouis J. IgnarroPeter NagyDavid A. WinkChristopher G. KevilMartin FeelischMiriam M. Cortese‐KrottChristopher L. BiancoYoshito KumagaiAdrian J. HobbsJoseph LinTomoaki IdaTakaaki Akaike

membrane biologyredox biologybiological hydropersulfidesbiochemistry

Nitric Oxide is Not Just Blowing in the Wind. British Journal of Pharmacology (2018)

Louis J Ignarro

public healthneuropharmacologyrespiratory medicinemedicinal chemistrymedicinepharmacologypharmacological researchnitric oxide

1
2
3
4
5
32
10 / page

Louis J. Ignarro

Professor Emeritus

University of California, Los Angeles

Affiliations

Samueli School of Engineering

Chemical and Biomolecular Engineering

David Geffen School of Medicine

Molecular & Medical Pharmacology

Louis J. Ignarro is currently serving as a Chemical And Biomolecular Engineering Professor Emeritus at University of California, Los Angeles.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Louis J. Ignarro

University of California, Los Angeles

Professor Emeritus

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Gasotransmitter Signaling in the Brain: New Frontiers for Therapeutics. Neurotherapeutics (2025)

neuropeptide receptorsneuronsneuropsychopharmacologyneuroscienceneurophysiologypharmacology

Exacerbated Neuropathy in Polar a and M Trials Due to Redox Interaction of Pledox-Associated Mn2+ and Oxaliplatin-Associated Pt2+. Antioxidants (2023)

Jan Olof G. KarlssonPer JyngeLouis J. Ignarro

neurologypharmacologymedicineoxidative stress

Comment on “Evidence That the Properdp Method is Inadequate for Protein Persulfidation Detection Due to Lack of Specificity”. Science Advances (2021)

biophysicsproperdp methodscientific communicationprotein scienceprotein persulfidation detectionscience advance

The Damaging Outcome of the Polar Phase III Trials Was Due to Avoidable Time-Dependent Redox Interaction Between Oxaliplatin and Pledox. Antioxidants (2021)

Jan Olof G. KarlssonPer JyngeLouis J. Ignarro

regenerative medicinepharmacologyredox biologyoncologydamaging outcome

Inhaled Nitric Oxide and Covid-19. British Journal of Pharmacology (2020)

Louis J. Ignarro

public healthinfectious respiratory diseasemedicinepharmacologycovid-19nitric oxide

May Mangafodipir or Other Sod Mimetics Contribute to Better Care in Covid-19 Patients?. Antioxidants (2020)

Jan Olof G KarlssonPer JyngeLouis J Ignarro

public healthclinical effectivenessmedicinepharmacologyoxidative stresscovid-19antioxidants

The Right Way to Breathe During the Coronavirus Pandemic. (2020)

infectious diseasesrespiratory medicinesars-cov-2lung microbiomecovid-19critical carevirus eradication

Jan Olof G. KarlssonPer JyngeIngemar LundströmLouis J. Ignarro

Biological Hydropersulfides and Related Polysulfides – a New Concept and Perspective in Redox Biology. FEBS Letters (2018)

Jon M. FukutoLouis J. IgnarroPeter NagyDavid A. WinkChristopher G. KevilMartin FeelischMiriam M. Cortese‐KrottChristopher L. BiancoYoshito KumagaiAdrian J. HobbsJoseph LinTomoaki IdaTakaaki Akaike

membrane biologyredox biologybiological hydropersulfidesbiochemistry

Nitric Oxide is Not Just Blowing in the Wind. British Journal of Pharmacology (2018)

Louis J Ignarro

public healthneuropharmacologyrespiratory medicinemedicinal chemistrymedicinepharmacologypharmacological researchnitric oxide

1
2
3
4
5
32
10 / page

Similar Faculty Members

Daria Mochly-Rosen

Institution

Stanford University

pharmacology

cardiology

Tadashi Inagami

Institution

Vanderbilt University

cardiovascular disease

hypertension

Jonathan S. Stamler

Institution

Case Western Reserve University

reactive nitrogen specie

nitrosative stress

Nigel Mackman

Institution

University of North Carolina at Chapel Hill

hemostasis

liver injury

Lu Cai

Institution

University of Louisville

heavy metals

health science

Walter J. Koch

Institution

Duke University

cardiology

cardiovascular research

Michal Toborek, M.D., Ph.D.

Institution

University of Miami

toxicology

nanotoxicology

Craig McClain

Institution

University of Louisville

hepatology

health science

Aruni Bhatnagar

Institution

University of Louisville

environmental toxicology

environmental aldehydes

Joshua M. Hare

Institution

University of Miami

stem cell research

stem cell therapy

Similar Faculty Members

Daria Mochly-Rosen

Institution

Stanford University

pharmacology

cardiology

Tadashi Inagami

Institution

Vanderbilt University

cardiovascular disease

hypertension

Jonathan S. Stamler

Institution

Case Western Reserve University

reactive nitrogen specie

nitrosative stress

Nigel Mackman

Institution

University of North Carolina at Chapel Hill

hemostasis

liver injury

Lu Cai

Institution

University of Louisville

heavy metals

health science

Walter J. Koch

Institution

Duke University

cardiology

cardiovascular research

Michal Toborek, M.D., Ph.D.

Institution

University of Miami

toxicology

nanotoxicology

Craig McClain

Institution

University of Louisville

hepatology

health science

Aruni Bhatnagar

Institution

University of Louisville

environmental toxicology

environmental aldehydes

Joshua M. Hare

Institution

University of Miami

stem cell research

stem cell therapy